| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Infant, Premature | 54 | 2025 | 814 | 9.310 |
Why?
|
| Infant Nutritional Physiological Phenomena | 26 | 2024 | 193 | 4.950 |
Why?
|
| Parenteral Nutrition | 18 | 2024 | 194 | 4.110 |
Why?
|
| Milk, Human | 25 | 2024 | 301 | 3.890 |
Why?
|
| Infant Formula | 23 | 2024 | 99 | 3.460 |
Why?
|
| Docosahexaenoic Acids | 14 | 2024 | 66 | 3.340 |
Why?
|
| Infant, Newborn | 103 | 2025 | 8189 | 3.310 |
Why?
|
| Infant, Premature, Diseases | 12 | 2025 | 241 | 3.030 |
Why?
|
| Nutritional Requirements | 14 | 2024 | 182 | 2.760 |
Why?
|
| Breast Feeding | 10 | 2024 | 220 | 2.480 |
Why?
|
| Fatty Acids, Unsaturated | 11 | 2017 | 65 | 2.060 |
Why?
|
| Infant | 65 | 2024 | 12488 | 1.750 |
Why?
|
| Ductus Arteriosus, Patent | 3 | 2024 | 145 | 1.660 |
Why?
|
| Lipids | 5 | 2021 | 516 | 1.540 |
Why?
|
| Ductus Arteriosus | 2 | 2024 | 63 | 1.430 |
Why?
|
| Gastroenterology | 10 | 2023 | 190 | 1.410 |
Why?
|
| Infant, Very Low Birth Weight | 9 | 2020 | 170 | 1.410 |
Why?
|
| Nutrition Policy | 6 | 2015 | 100 | 1.320 |
Why?
|
| Enterocolitis, Necrotizing | 8 | 2025 | 242 | 1.290 |
Why?
|
| Lactation | 5 | 2021 | 194 | 1.250 |
Why?
|
| Enteral Nutrition | 9 | 2024 | 256 | 1.200 |
Why?
|
| Dietary Supplements | 10 | 2024 | 478 | 1.150 |
Why?
|
| Epidermolysis Bullosa | 2 | 2024 | 18 | 1.130 |
Why?
|
| Arachidonic Acid | 7 | 2024 | 80 | 1.070 |
Why?
|
| Humans | 132 | 2025 | 124822 | 1.070 |
Why?
|
| Digestive System Abnormalities | 2 | 2024 | 35 | 1.050 |
Why?
|
| France | 16 | 2024 | 79 | 1.050 |
Why?
|
| Intensive Care Units, Neonatal | 9 | 2024 | 319 | 1.030 |
Why?
|
| Gestational Age | 18 | 2024 | 1161 | 0.940 |
Why?
|
| Infant, Small for Gestational Age | 3 | 2024 | 57 | 0.920 |
Why?
|
| Fatty Acids, Omega-3 | 3 | 2016 | 70 | 0.890 |
Why?
|
| Water-Electrolyte Balance | 1 | 2024 | 80 | 0.890 |
Why?
|
| Fetal Growth Retardation | 6 | 2024 | 240 | 0.890 |
Why?
|
| Dietary Fats, Unsaturated | 4 | 2013 | 34 | 0.890 |
Why?
|
| Female | 75 | 2024 | 66580 | 0.870 |
Why?
|
| Trace Elements | 2 | 2020 | 24 | 0.870 |
Why?
|
| Child Nutritional Physiological Phenomena | 3 | 2021 | 174 | 0.850 |
Why?
|
| Child Development | 12 | 2024 | 267 | 0.850 |
Why?
|
| Oligohydramnios | 1 | 2023 | 46 | 0.840 |
Why?
|
| Nutritional Status | 9 | 2024 | 314 | 0.840 |
Why?
|
| Fat Emulsions, Intravenous | 5 | 2018 | 76 | 0.830 |
Why?
|
| Urinary Tract | 1 | 2023 | 60 | 0.830 |
Why?
|
| Dietary Fats | 4 | 2020 | 298 | 0.820 |
Why?
|
| Urethral Obstruction | 1 | 2023 | 56 | 0.820 |
Why?
|
| Laser Coagulation | 1 | 2024 | 129 | 0.820 |
Why?
|
| Developmental Disabilities | 2 | 2024 | 709 | 0.810 |
Why?
|
| Esophageal Atresia | 5 | 2023 | 51 | 0.810 |
Why?
|
| Pregnancy | 20 | 2024 | 7172 | 0.810 |
Why?
|
| Infant Care | 4 | 2020 | 46 | 0.800 |
Why?
|
| Micronutrients | 2 | 2020 | 69 | 0.790 |
Why?
|
| Premature Birth | 2 | 2023 | 384 | 0.790 |
Why?
|
| Practice Guidelines as Topic | 8 | 2021 | 1267 | 0.750 |
Why?
|
| Infant, Extremely Low Birth Weight | 2 | 2012 | 38 | 0.740 |
Why?
|
| Fetofetal Transfusion | 1 | 2024 | 192 | 0.730 |
Why?
|
| Analgesics, Non-Narcotic | 2 | 2018 | 71 | 0.720 |
Why?
|
| Acetaminophen | 2 | 2018 | 94 | 0.710 |
Why?
|
| Breast Milk Expression | 1 | 2020 | 1 | 0.700 |
Why?
|
| Milk Banks | 1 | 2020 | 4 | 0.700 |
Why?
|
| Infant Food | 5 | 2022 | 81 | 0.690 |
Why?
|
| Patient Discharge | 3 | 2023 | 496 | 0.690 |
Why?
|
| Health Care Rationing | 1 | 2020 | 58 | 0.670 |
Why?
|
| Hemodynamics | 1 | 2024 | 850 | 0.660 |
Why?
|
| Milk Hypersensitivity | 3 | 2024 | 14 | 0.650 |
Why?
|
| Fetoscopy | 1 | 2024 | 439 | 0.650 |
Why?
|
| Diet | 7 | 2022 | 1138 | 0.650 |
Why?
|
| Birth Weight | 6 | 2024 | 348 | 0.640 |
Why?
|
| Sodium | 1 | 2020 | 295 | 0.620 |
Why?
|
| Growth | 3 | 2005 | 106 | 0.620 |
Why?
|
| Fetal Development | 3 | 2024 | 131 | 0.610 |
Why?
|
| Parenteral Nutrition, Total | 4 | 2021 | 113 | 0.610 |
Why?
|
| Short Bowel Syndrome | 3 | 2023 | 65 | 0.590 |
Why?
|
| Weight Gain | 5 | 2016 | 405 | 0.590 |
Why?
|
| Guideline Adherence | 4 | 2015 | 383 | 0.580 |
Why?
|
| Sodium, Dietary | 2 | 2020 | 35 | 0.570 |
Why?
|
| Male | 53 | 2024 | 61314 | 0.560 |
Why?
|
| Maternal Exposure | 1 | 2018 | 148 | 0.550 |
Why?
|
| Intensive Care, Neonatal | 5 | 2020 | 53 | 0.550 |
Why?
|
| Phosphorus | 2 | 2016 | 56 | 0.550 |
Why?
|
| Practice Patterns, Physicians' | 5 | 2024 | 724 | 0.540 |
Why?
|
| Food, Fortified | 6 | 2024 | 96 | 0.540 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2018 | 171 | 0.530 |
Why?
|
| Milk Proteins | 3 | 2024 | 92 | 0.510 |
Why?
|
| Infant, Extremely Premature | 4 | 2024 | 84 | 0.510 |
Why?
|
| Child, Preschool | 22 | 2024 | 14054 | 0.510 |
Why?
|
| Fatty Acids | 5 | 2020 | 351 | 0.490 |
Why?
|
| Retrospective Studies | 20 | 2024 | 16296 | 0.480 |
Why?
|
| Bronchiolitis | 2 | 2013 | 120 | 0.480 |
Why?
|
| Body Composition | 2 | 2010 | 524 | 0.480 |
Why?
|
| Cognition Disorders | 3 | 2016 | 554 | 0.470 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 607 | 0.470 |
Why?
|
| Cerebral Palsy | 1 | 2016 | 80 | 0.470 |
Why?
|
| Stiff-Person Syndrome | 1 | 2013 | 5 | 0.440 |
Why?
|
| Neurologic Examination | 2 | 2012 | 195 | 0.440 |
Why?
|
| Nervous System | 2 | 2012 | 127 | 0.440 |
Why?
|
| Bone Resorption | 2 | 2005 | 42 | 0.440 |
Why?
|
| Myoclonus | 1 | 2013 | 32 | 0.430 |
Why?
|
| Europe | 7 | 2024 | 354 | 0.430 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2016 | 225 | 0.430 |
Why?
|
| Creatinine | 3 | 2024 | 390 | 0.430 |
Why?
|
| Time Factors | 5 | 2020 | 6312 | 0.430 |
Why?
|
| Thoracic Wall | 1 | 2013 | 36 | 0.420 |
Why?
|
| Cardiovascular Diseases | 4 | 2017 | 1944 | 0.420 |
Why?
|
| Abdominal Wall | 1 | 2013 | 32 | 0.420 |
Why?
|
| Collagen | 2 | 2005 | 316 | 0.400 |
Why?
|
| Parents | 3 | 2016 | 1030 | 0.400 |
Why?
|
| Prospective Studies | 15 | 2023 | 6139 | 0.400 |
Why?
|
| Diarrhea | 1 | 2014 | 317 | 0.390 |
Why?
|
| Chlorides | 1 | 2012 | 106 | 0.390 |
Why?
|
| Child | 27 | 2024 | 24463 | 0.380 |
Why?
|
| Metabolic Diseases | 1 | 2013 | 130 | 0.370 |
Why?
|
| Respiratory Tract Infections | 1 | 2014 | 271 | 0.370 |
Why?
|
| Brain Damage, Chronic | 1 | 2011 | 30 | 0.370 |
Why?
|
| Nutrition Disorders | 1 | 2010 | 32 | 0.360 |
Why?
|
| Energy Intake | 6 | 2024 | 493 | 0.350 |
Why?
|
| Peptides | 2 | 2005 | 794 | 0.350 |
Why?
|
| Bone Density | 4 | 2004 | 320 | 0.340 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 3 | 2024 | 401 | 0.340 |
Why?
|
| Growth Charts | 2 | 2024 | 15 | 0.340 |
Why?
|
| Heart Defects, Congenital | 1 | 2021 | 1816 | 0.330 |
Why?
|
| Analgesics | 2 | 2025 | 134 | 0.330 |
Why?
|
| Probiotics | 2 | 2024 | 208 | 0.320 |
Why?
|
| Fatty Acids, Essential | 2 | 2009 | 4 | 0.320 |
Why?
|
| Pain Management | 2 | 2025 | 182 | 0.310 |
Why?
|
| Vitamins | 4 | 2022 | 108 | 0.300 |
Why?
|
| Calcification, Physiologic | 2 | 2004 | 22 | 0.290 |
Why?
|
| Dietary Sucrose | 2 | 2018 | 41 | 0.290 |
Why?
|
| Paris | 5 | 2020 | 10 | 0.290 |
Why?
|
| Gastroschisis | 2 | 2021 | 53 | 0.290 |
Why?
|
| Longitudinal Studies | 3 | 2020 | 1328 | 0.280 |
Why?
|
| Societies, Medical | 6 | 2024 | 689 | 0.280 |
Why?
|
| Treatment Outcome | 12 | 2024 | 12342 | 0.280 |
Why?
|
| Pain | 3 | 2025 | 462 | 0.270 |
Why?
|
| Cohort Studies | 8 | 2024 | 4786 | 0.270 |
Why?
|
| Sterol Esterase | 3 | 2016 | 19 | 0.260 |
Why?
|
| Pediatric Obesity | 3 | 2021 | 386 | 0.260 |
Why?
|
| alpha-Linolenic Acid | 3 | 2014 | 14 | 0.250 |
Why?
|
| Consensus | 4 | 2025 | 634 | 0.250 |
Why?
|
| Head | 2 | 2024 | 103 | 0.250 |
Why?
|
| Pregnancy in Diabetics | 1 | 2005 | 20 | 0.250 |
Why?
|
| Critical Illness | 2 | 2021 | 601 | 0.240 |
Why?
|
| Parenteral Nutrition Solutions | 2 | 2017 | 5 | 0.240 |
Why?
|
| Neonatology | 3 | 2024 | 51 | 0.240 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2016 | 1109 | 0.240 |
Why?
|
| Antacids | 1 | 2024 | 26 | 0.230 |
Why?
|
| Dehydration | 1 | 2024 | 39 | 0.230 |
Why?
|
| Histamine H2 Antagonists | 1 | 2024 | 49 | 0.230 |
Why?
|
| Pandemics | 2 | 2023 | 1106 | 0.220 |
Why?
|
| Intestinal Perforation | 1 | 2024 | 59 | 0.220 |
Why?
|
| Surveys and Questionnaires | 5 | 2016 | 3729 | 0.220 |
Why?
|
| Echovirus Infections | 1 | 2023 | 2 | 0.220 |
Why?
|
| Parenteral Nutrition, Home | 1 | 2023 | 7 | 0.220 |
Why?
|
| Follow-Up Studies | 6 | 2024 | 5156 | 0.210 |
Why?
|
| Diuresis | 1 | 2023 | 58 | 0.210 |
Why?
|
| United States Food and Drug Administration | 1 | 2024 | 149 | 0.210 |
Why?
|
| Epidermolysis Bullosa, Junctional | 1 | 2023 | 2 | 0.210 |
Why?
|
| Hyponatremia | 1 | 2024 | 73 | 0.210 |
Why?
|
| Fish Oils | 2 | 2017 | 83 | 0.210 |
Why?
|
| Urethra | 1 | 2023 | 84 | 0.210 |
Why?
|
| Biomarkers | 6 | 2020 | 3063 | 0.210 |
Why?
|
| Infant Health | 1 | 2023 | 16 | 0.210 |
Why?
|
| Amino Acids | 3 | 2023 | 665 | 0.210 |
Why?
|
| Esophageal Stenosis | 1 | 2023 | 44 | 0.210 |
Why?
|
| Infant, Low Birth Weight | 2 | 2013 | 168 | 0.210 |
Why?
|
| Intestinal Absorption | 2 | 2014 | 190 | 0.210 |
Why?
|
| Palm Oil | 2 | 2020 | 2 | 0.210 |
Why?
|
| Palmitates | 2 | 2020 | 19 | 0.210 |
Why?
|
| Retinopathy of Prematurity | 2 | 2020 | 56 | 0.210 |
Why?
|
| Enterovirus | 1 | 2023 | 52 | 0.200 |
Why?
|
| Enterovirus Infections | 1 | 2023 | 48 | 0.200 |
Why?
|
| Food Labeling | 2 | 2022 | 10 | 0.200 |
Why?
|
| Mouth Mucosa | 1 | 2002 | 52 | 0.200 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2017 | 1272 | 0.200 |
Why?
|
| Drug Prescriptions | 2 | 2024 | 221 | 0.190 |
Why?
|
| Phosphorus, Dietary | 2 | 2016 | 3 | 0.190 |
Why?
|
| Phospholipids | 1 | 2002 | 106 | 0.190 |
Why?
|
| Health Care Surveys | 2 | 2015 | 286 | 0.190 |
Why?
|
| Proton Pump Inhibitors | 1 | 2024 | 259 | 0.190 |
Why?
|
| Perinatal Care | 1 | 2002 | 67 | 0.190 |
Why?
|
| Communicable Disease Control | 1 | 2023 | 138 | 0.190 |
Why?
|
| White Matter | 1 | 2023 | 182 | 0.190 |
Why?
|
| Gastroesophageal Reflux | 1 | 2024 | 294 | 0.180 |
Why?
|
| Recommended Dietary Allowances | 2 | 2018 | 23 | 0.180 |
Why?
|
| Intelligence | 1 | 2021 | 98 | 0.180 |
Why?
|
| Communicable Diseases | 1 | 2023 | 160 | 0.180 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 2 | 2013 | 19 | 0.180 |
Why?
|
| Tissue Preservation | 1 | 2020 | 15 | 0.180 |
Why?
|
| Thoracoscopy | 1 | 2020 | 41 | 0.170 |
Why?
|
| Environmental Pollutants | 1 | 2021 | 69 | 0.170 |
Why?
|
| Risk Factors | 7 | 2022 | 10275 | 0.170 |
Why?
|
| Tracheoesophageal Fistula | 1 | 2020 | 48 | 0.170 |
Why?
|
| Jejunostomy | 1 | 2020 | 20 | 0.170 |
Why?
|
| Respiratory System Abnormalities | 1 | 2020 | 42 | 0.170 |
Why?
|
| Electrolytes | 1 | 2020 | 52 | 0.170 |
Why?
|
| Food Additives | 1 | 2020 | 6 | 0.170 |
Why?
|
| Contrast Media | 1 | 2024 | 471 | 0.170 |
Why?
|
| Bone Remodeling | 1 | 2000 | 56 | 0.170 |
Why?
|
| Ileostomy | 1 | 2020 | 31 | 0.170 |
Why?
|
| Lactose | 1 | 2020 | 54 | 0.170 |
Why?
|
| Patients' Rooms | 1 | 2019 | 8 | 0.170 |
Why?
|
| Thoracotomy | 1 | 2020 | 109 | 0.170 |
Why?
|
| Cholesterol, Dietary | 2 | 2014 | 46 | 0.160 |
Why?
|
| Logistic Models | 3 | 2014 | 1811 | 0.160 |
Why?
|
| Neurodevelopmental Disorders | 2 | 2024 | 506 | 0.160 |
Why?
|
| Maternal Age | 1 | 2020 | 132 | 0.160 |
Why?
|
| Cystoscopy | 1 | 2019 | 44 | 0.160 |
Why?
|
| Stress, Psychological | 2 | 2016 | 557 | 0.160 |
Why?
|
| Lower Urinary Tract Symptoms | 1 | 2019 | 31 | 0.160 |
Why?
|
| Intestines | 2 | 2016 | 574 | 0.160 |
Why?
|
| Insulin | 2 | 2022 | 1210 | 0.160 |
Why?
|
| Incidence | 2 | 2018 | 3144 | 0.160 |
Why?
|
| Prenatal Education | 1 | 2018 | 1 | 0.160 |
Why?
|
| Prescription Drugs | 1 | 2019 | 54 | 0.160 |
Why?
|
| Duodenum | 1 | 2019 | 99 | 0.160 |
Why?
|
| Fetal Therapies | 1 | 2019 | 72 | 0.150 |
Why?
|
| Hyperglycemia | 1 | 2020 | 224 | 0.150 |
Why?
|
| Pediatrics | 4 | 2021 | 1155 | 0.150 |
Why?
|
| Poisoning | 1 | 2018 | 16 | 0.150 |
Why?
|
| Leukocyte L1 Antigen Complex | 2 | 2009 | 15 | 0.150 |
Why?
|
| Cattle | 3 | 2024 | 568 | 0.150 |
Why?
|
| Urinary Bladder | 1 | 2019 | 245 | 0.150 |
Why?
|
| Hypertension | 2 | 2023 | 1316 | 0.150 |
Why?
|
| Gene Expression Regulation | 2 | 2004 | 2539 | 0.150 |
Why?
|
| Educational Status | 2 | 2022 | 274 | 0.150 |
Why?
|
| Electroencephalography Phase Synchronization | 1 | 2017 | 3 | 0.140 |
Why?
|
| Pregnancy Outcome | 3 | 2018 | 589 | 0.140 |
Why?
|
| Constriction, Pathologic | 1 | 2018 | 241 | 0.140 |
Why?
|
| Odds Ratio | 3 | 2017 | 1252 | 0.140 |
Why?
|
| Cerebrum | 1 | 2017 | 33 | 0.140 |
Why?
|
| Vision, Ocular | 2 | 2011 | 122 | 0.140 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2020 | 963 | 0.140 |
Why?
|
| Anthropometry | 2 | 2010 | 198 | 0.140 |
Why?
|
| Environmental Exposure | 1 | 2019 | 222 | 0.140 |
Why?
|
| Diaphragm | 1 | 2018 | 98 | 0.140 |
Why?
|
| Beverages | 1 | 2017 | 100 | 0.140 |
Why?
|
| Hypoglycemic Agents | 1 | 2020 | 443 | 0.140 |
Why?
|
| Osmolar Concentration | 1 | 2017 | 177 | 0.140 |
Why?
|
| Kidney | 1 | 2024 | 1353 | 0.140 |
Why?
|
| Animals | 12 | 2024 | 34195 | 0.130 |
Why?
|
| Vitamin K Deficiency Bleeding | 1 | 2016 | 4 | 0.130 |
Why?
|
| Milk | 3 | 2023 | 119 | 0.130 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2017 | 80 | 0.130 |
Why?
|
| Blood Glucose | 1 | 2020 | 1142 | 0.130 |
Why?
|
| Vitamin K | 1 | 2016 | 37 | 0.130 |
Why?
|
| Intestinal Volvulus | 1 | 2016 | 38 | 0.130 |
Why?
|
| Cordocentesis | 1 | 2016 | 10 | 0.130 |
Why?
|
| Hydrolysis | 1 | 2016 | 163 | 0.130 |
Why?
|
| Meta-Analysis as Topic | 2 | 2023 | 157 | 0.130 |
Why?
|
| Pierre Robin Syndrome | 1 | 2016 | 30 | 0.130 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2018 | 229 | 0.130 |
Why?
|
| Overweight | 1 | 2018 | 365 | 0.120 |
Why?
|
| Recombinant Proteins | 2 | 2016 | 1395 | 0.120 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2016 | 52 | 0.120 |
Why?
|
| Fetal Diseases | 1 | 2019 | 446 | 0.120 |
Why?
|
| Feeding Behavior | 2 | 2021 | 712 | 0.120 |
Why?
|
| Fetal Blood | 1 | 2016 | 176 | 0.120 |
Why?
|
| Cross-Sectional Studies | 3 | 2018 | 3447 | 0.120 |
Why?
|
| Guidelines as Topic | 2 | 2017 | 197 | 0.120 |
Why?
|
| Feces | 2 | 2009 | 717 | 0.120 |
Why?
|
| Measles | 1 | 2015 | 32 | 0.120 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2024 | 693 | 0.120 |
Why?
|
| Minerals | 1 | 1994 | 57 | 0.120 |
Why?
|
| Hospitalization | 2 | 2013 | 1782 | 0.110 |
Why?
|
| Eczema | 1 | 2014 | 27 | 0.110 |
Why?
|
| Night Care | 1 | 2014 | 3 | 0.110 |
Why?
|
| Cholestasis | 1 | 2016 | 153 | 0.110 |
Why?
|
| Clonazepam | 1 | 2013 | 5 | 0.110 |
Why?
|
| Adult | 8 | 2023 | 29484 | 0.110 |
Why?
|
| Receptors, Glycine | 1 | 2013 | 16 | 0.110 |
Why?
|
| Airway Obstruction | 1 | 2016 | 166 | 0.110 |
Why?
|
| Phlebotomy | 1 | 2013 | 16 | 0.110 |
Why?
|
| Thoracoplasty | 1 | 2013 | 3 | 0.110 |
Why?
|
| Otitis Media | 1 | 2014 | 84 | 0.110 |
Why?
|
| Risk Assessment | 4 | 2020 | 3436 | 0.110 |
Why?
|
| Growth Disorders | 1 | 2015 | 210 | 0.110 |
Why?
|
| Anus, Imperforate | 1 | 2013 | 20 | 0.110 |
Why?
|
| Pregnancy Complications | 1 | 2018 | 507 | 0.110 |
Why?
|
| Consanguinity | 1 | 2013 | 104 | 0.110 |
Why?
|
| Collagen Type I | 2 | 2005 | 112 | 0.110 |
Why?
|
| Anorectal Malformations | 1 | 2013 | 13 | 0.110 |
Why?
|
| Brain | 4 | 2023 | 3010 | 0.110 |
Why?
|
| Bacteria | 1 | 2017 | 485 | 0.110 |
Why?
|
| Protein-Energy Malnutrition | 1 | 2014 | 76 | 0.110 |
Why?
|
| Unnecessary Procedures | 1 | 2013 | 57 | 0.110 |
Why?
|
| Premedication | 1 | 2013 | 43 | 0.110 |
Why?
|
| Midazolam | 1 | 2013 | 49 | 0.110 |
Why?
|
| Hernia, Diaphragmatic | 1 | 2013 | 98 | 0.100 |
Why?
|
| Hernia, Umbilical | 1 | 2013 | 41 | 0.100 |
Why?
|
| Erythropoietin | 1 | 2013 | 104 | 0.100 |
Why?
|
| Retina | 2 | 2009 | 453 | 0.100 |
Why?
|
| Disease Outbreaks | 1 | 2015 | 323 | 0.100 |
Why?
|
| Lung | 1 | 2020 | 1488 | 0.100 |
Why?
|
| Feeding Methods | 1 | 2013 | 37 | 0.100 |
Why?
|
| Evidence-Based Medicine | 2 | 2013 | 633 | 0.100 |
Why?
|
| Placenta | 2 | 2023 | 507 | 0.100 |
Why?
|
| Neuropsychological Tests | 1 | 2016 | 926 | 0.100 |
Why?
|
| Quality of Life | 3 | 2023 | 1949 | 0.100 |
Why?
|
| Fetus | 2 | 2009 | 584 | 0.100 |
Why?
|
| Military Personnel | 1 | 2015 | 212 | 0.100 |
Why?
|
| Coconut Oil | 1 | 2011 | 2 | 0.100 |
Why?
|
| Olive Oil | 1 | 2011 | 22 | 0.100 |
Why?
|
| Hypnotics and Sedatives | 1 | 2013 | 136 | 0.100 |
Why?
|
| Nutrition Assessment | 1 | 2013 | 136 | 0.100 |
Why?
|
| Plant Oils | 1 | 2011 | 32 | 0.090 |
Why?
|
| Age Factors | 4 | 2021 | 2820 | 0.090 |
Why?
|
| Soybean Oil | 1 | 2011 | 70 | 0.090 |
Why?
|
| Blood Transfusion | 1 | 2013 | 309 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2002 | 3143 | 0.090 |
Why?
|
| Urogenital Abnormalities | 1 | 2013 | 155 | 0.090 |
Why?
|
| Triglycerides | 1 | 2014 | 573 | 0.090 |
Why?
|
| Fetal Nutrition Disorders | 1 | 2011 | 4 | 0.090 |
Why?
|
| Amblyopia | 1 | 2011 | 30 | 0.090 |
Why?
|
| Acidosis | 1 | 2012 | 94 | 0.090 |
Why?
|
| Exons | 1 | 2013 | 796 | 0.090 |
Why?
|
| Double-Blind Method | 3 | 2016 | 1637 | 0.090 |
Why?
|
| Axial Length, Eye | 1 | 2011 | 49 | 0.090 |
Why?
|
| Anticonvulsants | 1 | 2013 | 381 | 0.090 |
Why?
|
| Obesity | 2 | 2018 | 2279 | 0.090 |
Why?
|
| Cephalometry | 2 | 2024 | 33 | 0.090 |
Why?
|
| Heart Failure | 1 | 2024 | 2303 | 0.090 |
Why?
|
| Child Behavior Disorders | 1 | 2011 | 67 | 0.090 |
Why?
|
| Gene Deletion | 1 | 2013 | 795 | 0.090 |
Why?
|
| Neuromuscular Diseases | 1 | 2011 | 56 | 0.090 |
Why?
|
| Lipid Metabolism | 2 | 2004 | 359 | 0.090 |
Why?
|
| Visual Perception | 1 | 2011 | 124 | 0.090 |
Why?
|
| Malnutrition | 1 | 2013 | 204 | 0.080 |
Why?
|
| Case-Control Studies | 3 | 2024 | 3288 | 0.080 |
Why?
|
| Body Weight | 4 | 2024 | 1005 | 0.080 |
Why?
|
| Intubation, Intratracheal | 1 | 2013 | 293 | 0.080 |
Why?
|
| Anemia | 1 | 2013 | 340 | 0.080 |
Why?
|
| Industry | 1 | 2009 | 29 | 0.080 |
Why?
|
| Eye | 1 | 2011 | 227 | 0.080 |
Why?
|
| Psychometrics | 1 | 2013 | 676 | 0.080 |
Why?
|
| Patient Readmission | 1 | 2013 | 384 | 0.080 |
Why?
|
| Metabolic Syndrome | 1 | 2013 | 338 | 0.080 |
Why?
|
| Age of Onset | 1 | 2011 | 583 | 0.080 |
Why?
|
| Child Nutrition Sciences | 1 | 2009 | 19 | 0.080 |
Why?
|
| Swine | 2 | 2003 | 1173 | 0.080 |
Why?
|
| Electroencephalography | 1 | 2013 | 869 | 0.080 |
Why?
|
| Analgesics, Opioid | 1 | 2013 | 410 | 0.080 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2016 | 630 | 0.080 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 1425 | 0.080 |
Why?
|
| Patient Compliance | 1 | 2011 | 475 | 0.070 |
Why?
|
| Immunity | 1 | 2009 | 189 | 0.070 |
Why?
|
| Intestinal Diseases | 1 | 2009 | 83 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 1894 | 0.070 |
Why?
|
| Calcium | 3 | 2007 | 1099 | 0.070 |
Why?
|
| Reference Values | 3 | 2009 | 713 | 0.070 |
Why?
|
| Analgesia | 1 | 2008 | 45 | 0.070 |
Why?
|
| Heart Diseases | 1 | 2012 | 496 | 0.070 |
Why?
|
| Protein Hydrolysates | 2 | 2024 | 4 | 0.070 |
Why?
|
| Liver | 3 | 2004 | 1764 | 0.070 |
Why?
|
| Neurogenesis | 1 | 2009 | 190 | 0.070 |
Why?
|
| Pain Measurement | 2 | 2025 | 358 | 0.070 |
Why?
|
| Embryo, Mammalian | 1 | 2009 | 456 | 0.070 |
Why?
|
| Dietary Proteins | 1 | 2009 | 249 | 0.070 |
Why?
|
| Databases, Factual | 2 | 2024 | 1175 | 0.070 |
Why?
|
| Research Design | 1 | 2010 | 690 | 0.070 |
Why?
|
| Shock, Septic | 1 | 2008 | 146 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 2883 | 0.070 |
Why?
|
| Gastroenteritis | 1 | 2009 | 349 | 0.060 |
Why?
|
| Epilepsy | 1 | 2013 | 874 | 0.060 |
Why?
|
| Survival Rate | 1 | 2011 | 2036 | 0.060 |
Why?
|
| Pasteurization | 2 | 2016 | 2 | 0.060 |
Why?
|
| Animal Feed | 2 | 2003 | 79 | 0.060 |
Why?
|
| United States | 3 | 2024 | 10876 | 0.060 |
Why?
|
| Adipose Tissue | 3 | 2003 | 472 | 0.060 |
Why?
|
| Calcium, Dietary | 1 | 2004 | 37 | 0.060 |
Why?
|
| Behavior | 1 | 2005 | 74 | 0.060 |
Why?
|
| Zinc | 2 | 2020 | 128 | 0.060 |
Why?
|
| Absorptiometry, Photon | 1 | 2004 | 178 | 0.060 |
Why?
|
| Gastrointestinal Agents | 1 | 2024 | 60 | 0.060 |
Why?
|
| Eicosanoids | 1 | 2003 | 13 | 0.050 |
Why?
|
| Thermogenesis | 1 | 2004 | 49 | 0.050 |
Why?
|
| Gastrointestinal Diseases | 1 | 2007 | 333 | 0.050 |
Why?
|
| Enterovirus B, Human | 1 | 2023 | 7 | 0.050 |
Why?
|
| Failure to Thrive | 1 | 2024 | 90 | 0.050 |
Why?
|
| Non-Fibrillar Collagens | 1 | 2023 | 1 | 0.050 |
Why?
|
| Anastomotic Leak | 1 | 2023 | 28 | 0.050 |
Why?
|
| Oxidation-Reduction | 1 | 2004 | 443 | 0.050 |
Why?
|
| Food, Formulated | 1 | 2022 | 52 | 0.050 |
Why?
|
| Cheek | 1 | 2002 | 26 | 0.050 |
Why?
|
| Nutritive Value | 1 | 2022 | 91 | 0.050 |
Why?
|
| Autoantigens | 1 | 2023 | 119 | 0.050 |
Why?
|
| Cell Division | 1 | 2004 | 782 | 0.050 |
Why?
|
| Nitrogen | 1 | 2002 | 146 | 0.050 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2002 | 137 | 0.050 |
Why?
|
| Mental Disorders | 1 | 2009 | 823 | 0.050 |
Why?
|
| Primary Prevention | 1 | 2023 | 170 | 0.050 |
Why?
|
| Morbidity | 1 | 2022 | 244 | 0.050 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2023 | 238 | 0.050 |
Why?
|
| Water | 1 | 2022 | 185 | 0.050 |
Why?
|
| Allergens | 1 | 2023 | 252 | 0.050 |
Why?
|
| Transcription, Genetic | 2 | 2003 | 1704 | 0.050 |
Why?
|
| Bottle Feeding | 2 | 2016 | 36 | 0.050 |
Why?
|
| Nutritional Support | 1 | 2021 | 54 | 0.050 |
Why?
|
| Vitamin D | 1 | 2002 | 160 | 0.040 |
Why?
|
| Protective Factors | 1 | 2020 | 85 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 1019 | 0.040 |
Why?
|
| Thinness | 1 | 2000 | 70 | 0.040 |
Why?
|
| Prebiotics | 1 | 2020 | 23 | 0.040 |
Why?
|
| European Union | 1 | 2020 | 12 | 0.040 |
Why?
|
| Anastomosis, Surgical | 1 | 2020 | 169 | 0.040 |
Why?
|
| Cognition | 1 | 2005 | 731 | 0.040 |
Why?
|
| Operative Time | 1 | 2020 | 168 | 0.040 |
Why?
|
| Research | 1 | 2021 | 263 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2020 | 334 | 0.040 |
Why?
|
| Polypharmacy | 1 | 2019 | 40 | 0.040 |
Why?
|
| Palmitic Acid | 1 | 2019 | 34 | 0.040 |
Why?
|
| Muscle, Skeletal | 2 | 2003 | 953 | 0.040 |
Why?
|
| Child Health | 1 | 2020 | 53 | 0.040 |
Why?
|
| Vitamin D Deficiency | 1 | 2000 | 73 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2024 | 1027 | 0.040 |
Why?
|
| Public Health | 1 | 2021 | 260 | 0.040 |
Why?
|
| Phosphoproteins | 1 | 2000 | 405 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2004 | 807 | 0.040 |
Why?
|
| Respiratory Muscles | 1 | 2018 | 8 | 0.040 |
Why?
|
| Iron | 1 | 2021 | 268 | 0.040 |
Why?
|
| Life Style | 1 | 2021 | 414 | 0.040 |
Why?
|
| Dental Caries | 1 | 2017 | 10 | 0.040 |
Why?
|
| Respiration | 1 | 2018 | 120 | 0.040 |
Why?
|
| Clostridium | 1 | 2017 | 16 | 0.040 |
Why?
|
| Apoptosis | 1 | 2004 | 1792 | 0.030 |
Why?
|
| Glutens | 1 | 2017 | 10 | 0.030 |
Why?
|
| Food | 1 | 2017 | 125 | 0.030 |
Why?
|
| Societies | 1 | 2017 | 25 | 0.030 |
Why?
|
| Iron, Dietary | 1 | 2017 | 16 | 0.030 |
Why?
|
| Dietary Sugars | 1 | 2017 | 16 | 0.030 |
Why?
|
| Disability Evaluation | 1 | 2017 | 193 | 0.030 |
Why?
|
| Sex Factors | 1 | 2000 | 1285 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2004 | 1929 | 0.030 |
Why?
|
| Butylated Hydroxytoluene | 1 | 2016 | 12 | 0.030 |
Why?
|
| Chromatography, Gas | 1 | 2016 | 30 | 0.030 |
Why?
|
| Nutritional Sciences | 1 | 2017 | 76 | 0.030 |
Why?
|
| Liver Function Tests | 1 | 2016 | 101 | 0.030 |
Why?
|
| Carbon Radioisotopes | 1 | 2016 | 71 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2020 | 2092 | 0.030 |
Why?
|
| Injections, Intramuscular | 1 | 2016 | 196 | 0.030 |
Why?
|
| Hypothermia, Induced | 1 | 2017 | 166 | 0.030 |
Why?
|
| Dried Blood Spot Testing | 1 | 2016 | 21 | 0.030 |
Why?
|
| Placebos | 1 | 2016 | 241 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2017 | 370 | 0.030 |
Why?
|
| Status Epilepticus | 1 | 2017 | 144 | 0.030 |
Why?
|
| Advisory Committees | 1 | 2016 | 152 | 0.030 |
Why?
|
| Health Surveys | 1 | 2016 | 245 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2016 | 731 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2002 | 1473 | 0.030 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2017 | 190 | 0.030 |
Why?
|
| Edetic Acid | 1 | 2013 | 24 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2002 | 872 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2015 | 778 | 0.030 |
Why?
|
| Potassium | 1 | 1994 | 280 | 0.030 |
Why?
|
| Adolescent | 3 | 2018 | 19333 | 0.030 |
Why?
|
| Staphylococcus aureus | 1 | 2017 | 460 | 0.030 |
Why?
|
| Ferric Compounds | 1 | 2013 | 37 | 0.030 |
Why?
|
| Food Hypersensitivity | 1 | 2017 | 152 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2014 | 312 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2017 | 1402 | 0.030 |
Why?
|
| Parenting | 1 | 2017 | 332 | 0.030 |
Why?
|
| Self Report | 1 | 2016 | 520 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 1692 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 2902 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2018 | 1568 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2013 | 303 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 2143 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2004 | 4543 | 0.020 |
Why?
|
| Sensory Deprivation | 1 | 2011 | 11 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2023 | 3068 | 0.020 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2011 | 93 | 0.020 |
Why?
|
| Eicosanoic Acids | 1 | 2008 | 2 | 0.020 |
Why?
|
| Hospitals, University | 1 | 2008 | 97 | 0.020 |
Why?
|
| ROC Curve | 1 | 2009 | 567 | 0.020 |
Why?
|
| Cytosol | 1 | 2007 | 161 | 0.020 |
Why?
|
| Visual Acuity | 1 | 2011 | 824 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2008 | 258 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 2003 | 2825 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2017 | 3589 | 0.020 |
Why?
|
| Acyl-CoA Oxidase | 1 | 2003 | 9 | 0.010 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2003 | 27 | 0.010 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2003 | 25 | 0.010 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2003 | 49 | 0.010 |
Why?
|
| Oxidoreductases | 1 | 2003 | 93 | 0.010 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 2002 | 27 | 0.010 |
Why?
|
| Connective Tissue | 1 | 2002 | 21 | 0.010 |
Why?
|
| Random Allocation | 1 | 2003 | 437 | 0.010 |
Why?
|
| Femur | 1 | 2002 | 67 | 0.010 |
Why?
|
| Phantoms, Imaging | 1 | 2002 | 131 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2002 | 256 | 0.010 |
Why?
|
| Perilipin-1 | 1 | 2000 | 7 | 0.010 |
Why?
|
| Lipolysis | 1 | 2000 | 82 | 0.010 |
Why?
|
| Adipose Tissue, Brown | 1 | 2000 | 82 | 0.010 |
Why?
|
| Inflammation | 1 | 2007 | 1428 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 2000 | 309 | 0.010 |
Why?
|
| Cholesterol | 1 | 2002 | 536 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2002 | 582 | 0.010 |
Why?
|
| Prognosis | 1 | 2008 | 4615 | 0.010 |
Why?
|
| Middle Aged | 1 | 2016 | 26730 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 2000 | 778 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2000 | 1027 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2003 | 2060 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2000 | 3753 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2003 | 2609 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2000 | 4429 | 0.010 |
Why?
|
| Phenotype | 1 | 2000 | 4260 | 0.010 |
Why?
|
| Mice | 1 | 2000 | 17747 | 0.000 |
Why?
|